// App-Quantinova.ai

: Palovarotene for the treatment of fibrodysplasia ossificans progressiva: methodology of the phase III open-label PIVOINE rollover trial

Researchers

Presenter

  • Alexander Artyomenko

Principal Investigators

  • Aude Houchard

  • Azzeddine Zemam

Medical Centers

  • Ipsen Ltd, Slough, UK

  • Ipsen, Boulogne-Billancourt, France

Locations

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

Disease

  • Fibrodysplasia ossificans progressiva

  • Acquired immunodeficiency syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Palovarotene

Outcome

  • N/A

Study Design

  • Open Label

Phase

  • III

Study Id's

  • NCT03312634

  • NCT05027802

  • NCT02979769

Sponsors

  • Ipsen

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved